Viewing StudyNCT00632268



Ignite Creation Date: 2024-05-05 @ 7:15 PM
Last Modification Date: 2024-10-26 @ 9:46 AM
Study NCT ID: NCT00632268
Status: COMPLETED
Last Update Posted: 2013-08-21
First Post: 2008-03-03

Brief Title: Low-dose RAD001Everolimus Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer
Sponsor: National Taiwan University Hospital
Organization: National Taiwan University Hospital

Conditions & Keywords Data

Conditions:
Name
Metastatic Gastric Cancer
Keywords:
Name View
high-dose 5-FU View
mTOR inhibitor View
RAD001 View
everolimus View
chemotherapy View
cisplatin View